Radionuclide therapy of inflammatory joint diseases
- 1 September 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Nuclear Medicine Communications
- Vol. 23 (9) , 829-831
- https://doi.org/10.1097/00006231-200209000-00003
Abstract
Inflammatory joint diseases as well as arthropathy are common joint diseases. Many of them may be treated by synovectomy to stop disease progression and to improve joint function. Radiosynoviorthesis as one therapeutic procedure of rheumatoid arthritis, other inflammatory joint diseases, persistent synovial perfusion, and other joint diseases is widely used in many countries in Europe. Using Y-90 for the knee joint, Re-186 for middle sized joints and Er-169 for small joints an improvement of symptoms and function may be observed in about 60-80% of patients.Keywords
This publication has 6 references indexed in Scilit:
- Yttrium radiosynoviorthesis in the treatment of knee arthritis in rheumatoid arthritis: a systematic reviewAnnals of the Rheumatic Diseases, 2000
- Die Radiosynoviorthese im Behandlungsplan chronisch-entzündlicher GelenkerkrankungenZeitschrift für Rheumatologie, 1999
- Radionuclide therapy practice and facilities in EuropeEuropean Journal of Nuclear Medicine and Molecular Imaging, 1999
- Chronische Polyarthritis und Radiosynoviorthese: Eine prospektive, kontrollierte Studie der Injektionstherapie mit Erbium-169 und Rhenium-186 (Radiosynoviorthesis in Rheumatoid Arthritis: A prospective study of injectiontherapy with rhenium-186 and erbium-169)Zeitschrift für Rheumatologie, 1997
- Yttrium synovectomy: a meta‐analysis of the literatureAustralian and New Zealand Journal of Medicine, 1993
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988